Arkolith/Insider Trading/VOR/Form 4

RA Capital Nexus Fund, L.P.

DirectorVor Biopharma Inc. (VOR) · full profile →Form 4 · filed Oct 22, 2025
Net Selling
Open-Market Buys
$0
Open-Market Sells
$3.4M
Net Open-Market Flow
-$3.4M
Transactions
5
5 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Oct 21, 2025Sell(S)25K$28.11$704K1.4M
Oct 20, 2025Sell(S)14K$29.63$409K1K
Oct 20, 2025Sell(S)70K$29.63$2.1M1.4M
Oct 20, 2025Sell(S)1K$30.12$39K0
Oct 20, 2025Sell(S)7K$30.12$197K1.4M

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001231919-25-000342) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML